Secondhand smoke inhibits both Cl- and K+ conductances in normal human bronchial epithelial cells by Savitski, Amy N et al.
BioMed  Central
Page 1 of 13
(page number not for citation purposes)
Respiratory Research
Open Access Research
Secondhand smoke inhibits both Cl- and K+ conductances in normal 
human bronchial epithelial cells
Amy N Savitski1, Clementina Mesaros3, Ian A Blair3, Noam A Cohen4 and 
James L Kreindler*1,2
Address: 1Division of Pulmonary Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA, 2Department of Pediatrics, University 
of Pennsylvania School of Medicine, Philadelphia, PA, USA, 3Centers for Cancer Pharmacology and Excellence in Environmental Toxicology, 
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA and 4Division of Rhinology, Department of 
Otorhinolaryngology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Email: Amy N Savitski - amy.savitski@gmail.com; Clementina Mesaros - mesaros@mail.med.upenn.edu; 
Ian A Blair - ianblair@exchange.upenn.edu; Noam A Cohen - noam.cohen@uphs.upenn.edu; James L Kreindler* - kreindler@email.chop.edu
* Corresponding author    
Abstract
Secondhand smoke (SHS) exposure is an independent risk factor for asthma, rhinosinusitis, and
more severe respiratory tract infections in children and adults. Impaired mucociliary clearance with
subsequent mucus retention contributes to the pathophysiology of each of these diseases,
suggesting that altered epithelial salt and water transport may play an etiological role. To test the
hypothesis that SHS would alter epithelial ion transport, we designed a system for in vitro exposure
of mature, well-differentiated human bronchial epithelial cells to SHS. We show that SHS exposure
inhibits cAMP-stimulated, bumetanide-sensitive anion secretion by 25 to 40% in a time-dependent
fashion in these cells. Increasing the amount of carbon monoxide to 100 ppm from 5 ppm did not
increase the amount of inhibition, and filtering SHS reduced inhibition significantly. It was
determined that SHS inhibited cAMP-dependent apical membrane chloride conductance by 25%
and Ba2+-sensitive basolateral membrane potassium conductance by 50%. These data confirm
previous findings that cigarette smoke inhibits chloride secretion in a novel model of smoke
exposure designed to mimic SHS exposure. They also extend previous findings to demonstrate an
effect on basolateral K+ conductance. Therefore, pharmacological agents that increase either apical
membrane chloride conductance or basolateral membrane potassium conductance might be of
therapeutic benefit in patients with diseases related to SHS exposure.
Introduction
Tobacco use is a worldwide epidemic accounting for 3%
of the world's morbidity and mortality at a cost of tens of
billions of U.S. dollars annually [1]. Even in the United
States of America, where smoking rates have declined over
the last 4 decades, the prevalence of smoking among
adults and teenagers remains approximately 22-24%,
meaning that more than 66,000,000 people smoke regu-
larly [1,2]. The wide prevalence of smoking means that
many children and adults are exposed to SHS. A recent
study released by the Social Climate Survey of Tobacco
from the Mississippi State University http://socialcli
mate.org/ suggested that more than 40% of American
children are exposed to secondhand smoke (SHS). This
exposure is a significant risk factor for respiratory diseases,
including lower airways infections, chronic rhinosinusitis,
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middle ear infection, and asthma in adults [3], as well as
asthma and more severe respiratory syncytial virus (RSV)
infection in children [4,5]. These diseases, while clearly
multifactorial, all share a component of impaired muco-
ciliary clearance (MCC) and mucus retention.
Maintenance of normal MCC in the respiratory tract
depends on salt and water transport by respiratory epithe-
lial cells. MCC is disrupted when epithelial salt and water
transport is abnormal, as in cystic fibrosis (CF). Previous
studies from our and others' laboratories demonstrated
that components of cigarette smoke inhibited chloride
(Cl-) secretion in polarized epithelia [6-8]. Mainstream
cigarette smoke inhibited both CFTR expression and func-
tion both in vitro in immortalized cell lines and in vivo
where nasal potential difference measurements were con-
sistent with inhibition of Cl- transport similar to that seen
in cystic fibrosis [9]. These findings led us to hypothesize
that SHS may have similar effects on epithelial Cl- trans-
port.
To test this hypothesis, we designed a system for in vitro
exposure of mature, well-differentiated human bronchial
epithelial cells (HBECs) to SHS. SHS (sometimes called
environmental tobacco smoke or ETS) is a dilute combi-
nation of sidestream smoke released from burning ciga-
rettes and a smaller amount of mainstream smoke
exhaled by smokers. The components of SHS vary in con-
centration over time and distance from the source ciga-
rette(s) [10,11]. A number of markers have been used to
monitor the amount of SHS in the environment, includ-
ing carbon monoxide (CO) and total suspended particu-
late (TSP) [12]. Though neither CO nor TSP is specific for
SHS [13], they are easily measured and are correlated in
non-ventilated conditions [14]. In households and cars,
where most children are exposed to SHS, CO levels are in
the range of 2.5-6 ppm [10,14], and thus we used this as
the target exposure level in the majority of our experi-
ments.
We measured baseline, amiloride-sensitive, cAMP-stimu-
lated, and ATP-stimulated short-circuit current (ISC) in air
(sham)-exposed and SHS-exposed HBECs. SHS inhibited
forskolin-stimulated and ATP-stimulated ISC. Inhibition
by SHS was not due to reduced cAMP production or pro-
tein kinase A (PKA) activity. Rather, SHS inhibited both
apical CFTR conductance and basolateral, Ba2+-sensitive
K+  conductance, which provides the electrical driving
force for Cl- secretion in airway epithelia. These data sup-
port the hypothesis that SHS and primary cigarette smoke
have similar effects on transepithelial ion transport in
well-differentiated HBECs, and they suggest that therapies
aimed at improving epithelial Cl- secretion may be bene-
ficial for people exposed to SHS.
Materials and methods
Cell culture
HBECs were purchased from Lonza (Walkersville, MD,
USA), and cultured according to Gray and colleagues [15].
P2 HBECs were seeded into plastic T-75 flasks (Costar,
Corning, Lowell, MA, USA) and grown in Bronchial Epi-
thelial Cell Growth Medium (BEGM) (Lonza) supple-
mented with Ultroser-G (Pall Corporation, East Hills, NY,
USA) (0.5% v/v), bovine pituitary extract (52 μg/mL),
hydrocortisone (0.5 μg/mL), human recombinant EGF
(0.5 ng/mL), epinephrine (0.5 μg/mL), transferrin (10 μg/
mL), insulin (5 μg/mL), retinoic acid (0.1 μg/mL), triio-
dothyronine (6.5 μg/mL), gentamicin (50 μg/mL) and
amphotericin-B (50 ng/mL). The medium was changed
every 48 h until cells were 90% confluent. Cells were then
collected and seeded at a density of 6 - 8 × 104 per 0.33
cm2 onto Transwell permeable inserts (Costar) in differen-
tiation media containing 50% DMEM in BEGM with the
same supplements as above but lacking triiodothyronine
and with a final retinoic acid concentration of 50 nM (all-
trans retinoic acid; Sigma, ST. Louis, MO, USA). HBECs
were maintained submerged for the first 7 d and then
exposed to an apical air interface for the remainder of the
culture period. The differentiation medium was refreshed
2 times each week. At all stages of culture, cells were main-
tained at 37°C in 5% CO2 in an air incubator. Under these
conditions, HBECs formed a well-differentiated mucocili-
ary phenotype with the classical ion transport phenotype
associated with this tissue. HBECs were generally used
between 4 and 8 weeks of age. We estimate that our cul-
tures were 30 - 50% ciliated. A total of 7 donor cell lots
were used to complete these studies and each experiment
was performed using at least 2 different donor cell lots.
Smoke exposure
SHS was generated using a custom-designed exposure sys-
tem (Fig. 1A) similar to those used for in vivo SHS research
[16]. Standardized research cigarettes (University of Ken-
tucky, 1R5F) were ignited in an automated smoking
machine (Teague TE-10, Teague Enterprises, Davis, CA,
USA). Sidestream smoke was collected by negative pres-
sure into a chimney above the burning cigarette. The TE-
10 smoking machine puffer pump (PP) was programmed
to take a 2 s, 35 mL puff of the burning cigarette every
minute and mix the mainstream smoke (MS) with side-
stream smoke (SS). Although the exact ratio of main-
stream and sidestream smoke in the environment is
unknown, this timing was designed to mimic a smoker
inhaling and exhaling mainstream smoke once every
minute. The mixture of sidestream and mainstream
smoke, which we call whole cigarette smoke (WCS), was
drawn into a mixing and dilution chamber (MDC) where
it was mixed with room air by a fan (F). The dilute WCS,
which we designate SHS, was then drawn at 5 L/min intoRespiratory Research 2009, 10:120 http://respiratory-research.com/content/10/1/120
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Smoke Exposure System and quantification of exposure Figure 1
Smoke Exposure System and quantification of exposure. A) Secondhand smoke (SHS) was generated as described in 
the text. B) CO levels in the exposure chamber can be varied by diluting a single cigarette's smoke with fresh air (Dilute) or by 
smoking more than one cigarette simultaneously as indicated by the number of cigarettes shown above the tracing. Tempera-
ture and humidity (C) and carbon monoxide (D) are held constant after an initial equilibration period. E) Nicotine can be 
recovered from the mucosal surface of cells in the exposure chamber but not from sham-exposed cells. F) Sham and SHS-
exposed (SHS) HBECs released LDH into the serosal exposure buffer to the same degree, and both released significantly less 
than cells permeabilized with 0.1% Triton-X100 as a positive control (PC) (*** p < 0.001 compared to both sham and SHS by 
one-way ANOVA with Tukey's post-tests, n = 4 inserts per condition). Exposure buffer not exposed to cells is shown as a neg-
ative control (NC) to demonstrate background.Respiratory Research 2009, 10:120 http://respiratory-research.com/content/10/1/120
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a heated, humidified exposure chamber (EC) where the
cells rested in HEPES-buffered solution (exposure buffer)
on their serosal side and with their mucosal surface
exposed. CO concentration in parts per million (ppm)
was continuously monitored with a TSI Q-trak indoor air
quality meter (AQM). When CO reached 4-5 ppm, the
level of CO in SHS in households and cars, the inlet and
outlet tubing connected to the exposure chamber were
clamped with hemostats for the duration of the exposure.
Sham (air) exposure was accomplished by placing cells
with their apical surface exposed in a 37°C, 100% humid-
ified, 0% CO2 incubator.
Surface nicotine measurements by liquid chromatography/
mass spectrometry
Liquid chromatography-mass spectrometry (LC-MS) was
performed using a Waters Alliance 2690 HPLC system
(Waters Corp., Milford, MA, USA). Gradient elution was
performed in the linear mode using a Discovery HS F col-
umn (150 × 4 mm i.d., 5 mm; Sigma-Aldrich, St. Louis,
MO) at a flow rate of 0.3 mL/min at ambient temperature.
MS was conducted with a Thermo Finnigan TSQ Quan-
tum Ultra AM mass spectrometer (Thermo Fisher, San
Jose, CA) equipped with a heated electrospray ionization
(HESI) source operated in the positive ion mode. Unit res-
olution was maintained for both parent and product ions
for multiple reaction monitoring (MRM) analyses. Oper-
ating conditions were as follows: spray voltage was 3500
V, vaporizer temperature was 300°C, and heated capillary
temperature was 280°C. Nitrogen was used for the sheath
gas and auxiliary gas set at 25 and 10 (in arbitrary units),
respectively. Collision induced dissociation (CID) was
performed using argon as the collision gas at 1.5 mTorr in
the second (rf-only) quadrupole. An additional dc offset
voltage was applied to the region of the second multipole
ion guide (Q0) at 5 V. The MRM transition for nicotine
was m/z 163 to m/z 84 (collision energy, 25 eV). Auto-
mated sample acquisition and data analysis were per-
formed using the Xcalibur software (Thermo Scientific).
Calibration curves were generated based on the peak-area
ratios (analyte/internal standard) from 5 nM to 5 μM.
Typical r2 values were 0.995 or greater and the accuracy
was between 90% and 100%.
Short circuit current (ISC) measurements
Transwell inserts containing HBECs were mounted in a
vertical Ussing chamber. HBEC monolayers were continu-
ously clamped to 0 mV after fluid resistance compensa-
tion using an automatic voltage clamp (VCC 600,
Physiologic Instruments, San Diego, CA, USA). ISC was
digitized at 0.1 Hz, and data were stored on a computer
hard drive using Acquire and Analyze software build 2.3.0
(Physiologic Instruments). Transepithelial resistance (RT)
was determined automatically by the software using a
bipolar 200 ms, 3 mV voltage pulse once per s, recording
the change in ISC, and calculating RT from Ohm's law (RT
= ΔV/ΔI). ISC was allowed to stabilize at the beginning of
each experiment and after each drug addition. By conven-
tion, an upward deflection in the ISC tracing represents
anion secretion or cation absorption.
cAMP, PKA, and lactate dehydrogenase (LDH) 
measurements
Whole-cell cAMP levels and PKA activity, and LDH
released by sham or SHS-exposed HBECs were measured
using colorimetric assays according to manufacturer's
instructions (Stressgen (Ann Arbor, MI, USA), Calbio-
chem (EMD Biosciences/Merck KGaA, Darmstadt, Ger-
many), and Sigma, respectively). cAMP levels were
measured in whole cell lysates collected after a 10 min
incubation in 0.1 N HCl. cAMP levels were extrapolated
from a standard curve are reported in pmol/mL. PKA lev-
els were measured in whole cell lysates collected in a sam-
ple preparation buffer provided by the manufacturer. PKA
activity is reported as absorbance units per microgram
total protein used in the assay × 100. Total protein was
determined by bicinchoninic acid assay (Sigma). LDH, a
measure of release of intracellular components secondary
to cytotoxicity, is reported as absorbance units.
Solutions
During exposure (either sham or SHS) cells were bathed
on the serosal side with a solution containing (in mM):
120 NaCl, 25 n-methyl-d-glucamine chloride (NMDG-
Cl), 3.3 KH2PO4, 0.8 K2HPO4, 1.2 MgCl2, 1.2 CaCl2, 10
glucose and 10 HEPES, pH 7.4. This was done to mini-
mize any possible effects of pH because no additional
CO2 was added to the sham chamber or SHS exposure
chamber. Ussing chamber solutions are detailed in Table
1.
Chemicals
Amiloride (Sigma) was dissolved in distilled, deionized
water as 1000× stock. Forskolin (Calbiochem) was dis-
solved in DMSO as a 5000× stock. Bumetanide (Sigma)
was dissolved in ethanol as a 1000× stock. The CFTR
inhibitors glycine hydrazide-101 (GlyH-101) [17] and
CFTRinh-172 [18], generous gifts of Dr. Robert J Bridges,
Rosalind Franklin University and Cystic Fibrosis Founda-
tion Therapeutics (CFFT), were dissolved in DMSO as
1000× stocks. 5,6-Dichloro-1-ethyl-1,3-dihydro-2H-ben-
zimidazol-2-one (DC-EBIO) (Tocris, Ellisville, MO, USA)
was dissolved in DMSO as a 1000× stock.
Data Presentation and Statistical analysis
We report ISC data in two ways. In the text, we report mean
ISC +/- standard error for the total number of inserts used
to complete each experiment. We observed significant
donor-to-donor and lot-to-lot variability in forskolin-Respiratory Research 2009, 10:120 http://respiratory-research.com/content/10/1/120
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stimulated ISC. For example, in our initial group of exper-
iments examining acute exposure to SHS with 5 ppm CO
the inter-donor forskolin-stimulated ISC ranged from 0.6
μA/cm2 to 29 μA/cm2. In the same experiments, the intra-
donor variability in forskolin-stimulated ISC was as high as
50%. To account for this variability, data were normalized
by calculating the mean change in ISC  for the sham-
exposed HBECs from a given donor on the day of experi-
mentation and normalizing each sham and SHS-exposed
insert tested on that day by this result. Because we were
interested in the relative change in ISC with SHS exposure,
statistical comparisons were performed on the normal-
ized data. Bar graphs of normalized data are presented so
that the direction of the bar is consistent with the direc-
tion of change in ISC. Comparisons between groups with
equal variances were made with unpaired t-tests, and
comparisons between groups with unequal variances were
made with unpaired t-tests using Welch's correction. All
statistical comparisons were made using Prism 5 (Graph-
Pad Software, San Diego, CA). Significance was defined as
a p value = 0.05.
Results
Quantification of CO and nicotine exposure
CO concentration in the exposure chamber was used as a
surrogate marker for SHS exposure and was measured
using a TSI Q-Trak air quality monitor (TSI Inc., Shore-
view, MN). Depending on the number of cigarettes simul-
taneously smoked and the amount of fresh air drawn into
the mixing and dilution chamber, the system generated
between 0 and 200 ppm CO (Fig. 1B). Temperature and
humidity were maintained at physiological values (Fig.
1C). By clamping the inlet and outlet tracts of the expo-
sure chamber, CO concentration could be held within a
narrow range (5 - 10 ppm) (Fig. 1D), although there was
a slow drift of CO. To demonstrate deposition of a known
constituent of cigarette smoke onto cells in the chamber,
we placed 200 μl of warm PBS on the apical surface of
HBECs exposed to SHS for 30 min and measured nicotine
in the collected mucosal surface washes by mass spec-
trometry. Nicotine was not detected in sham-exposed
HBECs. Nicotine was detected in all samples exposed to
SHS, and there was more nicotine deposited on HBECs
exposed to 30 and 100 ppm CO compared with 5 ppm (n
= 6 inserts for 5 ppm, 4 inserts for 30 ppm, and 4 inserts
for 100 ppm, p < 0.001 for both by one-way ANOVA with
Tukey's post-tests), but there was no statistically signifi-
cant difference between 30 and 100 ppm (Fig. 1E).
Exposure to SHS did not change RT or increase LDH 
release
To determine if SHS caused cellular toxicity that impaired
membrane integrity, we measured RT  as well as LDH
release following SHS exposure. HBECs were exposed to
either air (sham) or SHS for 180 min (the longest expo-
sure time used in subsequent experiments). Immediately
following exposure, the Transwell inserts were mounted
in Ussing chambers and the transepithelial potential was
clamped to 0 mV. Baseline RT was not different between
sham and SHS-exposed HBECs after 180 min exposure
(936 ± 86 Ωcm2 vs. 926 ± 63 Ωcm2, respectively, n = 19
inserts, 3 donors, p = 0.9). In addition, there was no dif-
ference in the amount of LDH released into the exposure
medium of sham versus SHS-exposed cells (n = 4 inserts
for each condition, p = 0.4). As a control, significant LDH
release was detected in cells that had their mucosal surface
exposed to 0.1% Triton-X100 (Fig. 1F, p < 0.001 by one-
way ANOVA). Together, these data suggest that acute SHS
exposure does not cause a generalized disruption of epi-
thelial integrity. However, it should be noted that LDH
release into exposure media measures primarily basola-
teral membrane integrity, whereas the apical membrane
of the cells received the direct exposure.
SHS inhibits cAMP and ATP-stimulated Cl- secretion
To determine the acute effect of SHS on transepithelial ion
transport, HBECs were exposed to air (sham) or SHS (5 -
10 ppm CO) for 30 min and then immediately mounted
Table 1: Ussing chamber solutions (in mM)
Normal buffer High Cl- Low Cl- High K+ Low K+
NaCl 120 145 25 25
NaHCO3
- 25
K2HPO4 0.8 0.8 0.8 0.8 0.8
KH2PO4 3.3 3.3 3.3 3.3 3.3
CaCl2 1.2 1.2 1.2 1.2 1.2
MgCl2 1.2 1.2 1.2 1.2 1.2
Na gluconate 145 120
K gluconate 120
Glucose 10 10 10 10 10
HEPES 10 10 10 10
Gas lift 95% O2/5% CO2 Air Air Air Air
pH 7.4 7.4 7.4 7.4Respiratory Research 2009, 10:120 http://respiratory-research.com/content/10/1/120
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in Ussing chambers. Baseline ISC and RT were recorded
prior to the sequential addition of amiloride, forskolin,
and bumetanide (Fig. 2A). Baseline ISC and RT were not
different between sham and SHS-exposed HBECs (Base-
line ISC: 11.5 ± 1.0 for sham vs. 10.4 ± 1.0 μA/cm2 for SHS,
n = 32 inserts, 5 donors, p = ns; Baseline RT: 1261 ± 145
for sham vs. 1429 ± 162 Ωcm2 for SHS, p = 0.44). Simi-
larly, amiloride-sensitive ISC was not different between
sham and SHS-exposed cells, suggesting that acute SHS
exposure did not affect ENaC-mediated Na+ absorption
(Fig. 2B, left bars). In contrast, SHS exposure (30 min, 5
ppm CO) reduced forskolin-stimulated ISC by 25% (14.2
± 1.3 μA/cm2 for sham vs. 9.7 ± 1.0 μA/cm2 for SHS, n =
32 inserts, 5 donors, p < 0.01) (Fig. 2B, middle bars). This
reduction in forskolin-stimulated ISC was paralleled by a
reduction in bumetanide-sensitive ISC (Fig. 2B, right bars),
suggesting that SHS specifically reduced Cl-  secretion
[19,20]. To investigate if the reduction in forskolin-stimu-
lated ISC was dependent on CFTR, a similar experiment
was performed in which HBECs were sham or SHS-
exposed for 10 min, mounted in Ussing chambers, and
sequentially exposed to amiloride, forskolin, and
CFTRinh-172. Similar to the results seen with bumeta-
nide, CFTRinh172-sensitive ISC was reduced to the same
extent as forskolin-stimulated ISC (Fig. 2C), strongly sug-
gesting that SHS inhibits CFTR-dependent Cl- secretion.
SHS inhibits forskolin-stimulated Cl- secretion Figure 2
SHS inhibits forskolin-stimulated Cl- secretion. A) Representative ISC tracing after 30 min sham (open circles) or SHS 
exposure (gray circles). Note that the decrease in forskolin-stimulated ISC in SHS-exposed HBECs is completely accounted for 
by a decrease in bumetanide sensitive ISC. B) Normalized changes in ISC with amiloride, forskolin, and bumetanide (** p < 0.01 
and *** p < 0.001 by unpaired t-test, n = 32 inserts, 5 donors). C) Normalized changes in ISC with forskolin and CFTRinh-172 
(** p < 0.01 and *** p < 0.001 by unpaired t-test, n = 6 filters, 2 donors).Respiratory Research 2009, 10:120 http://respiratory-research.com/content/10/1/120
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To investigate the effect of SHS on Ca2+-activated Cl- secre-
tion, HBECs were either sham or SHS-exposed for 180
min (the longest duration of exposure used in the cAMP
experiments, see below) and then immediately mounted
in Ussing chambers. Amiloride and then ATP (200 μM)
were sequentially added to the mucosal bath. Addition of
ATP resulted in a large peak in ISC followed by a plateau.
After 180 min of SHS peak ATP-stimulated ISC was inhib-
ited by 40% (33.1 ± 5.2 μA/cm2 for sham vs. 18.4 ± 2.0
μA/cm2 for SHS, n = 7 inserts, 2 donors, p = 0.02 by
unpaired t-test) whereas plateau ISC was inhibited by 30%
(11.4 ± 1.1 mA/cm2 for sham vs. 8.1 ± 1.0 mA/cm2 for
SHS, p = 0.04 by unpaired t-test).
The effect of SHS on forskolin-stimulated Cl- secretion is 
time-dependent and not reversible up to 24 hrs
Our previous data using water-soluble cigarette smoke
extract (CSE) suggested that water-soluble components of
cigarette smoke inhibited forskolin-stimulated ISC after as
little as 5 min, but that maximal inhibition was not
achieved for approximately 30 min [6]. After 3 min of SHS
exposure, forskolin-stimulated ISC  was not different
between SHS-exposed HBECs and sham controls (9.5 ±
1.5  μA/cm2 vs. 9.2 ± 0.8 μA/cm2, respectively, n = 13
inserts, 3 donors, p = 0.87) (Fig. 3A). After 10 min or 60
min, forskolin-stimulated ISC was reduced by approxi-
mately 20%, a trend that did not reach significance for the
raw data but did for the normalized data (10 min: 17.5 ±
2.2 μA/cm2 for sham vs. 13.1 ± 1.4 μA/cm2 for SHS, n = 8
inserts, 2 donors, p = 0.15; 60 min: 13.7 ± 1.0 μA/cm2 for
sham vs. 11 ± 1.0 μA/cm2 for SHS, n = 17 inserts, 3
donors, p = 0.07). After 180 min, forskolin-stimulated Cl-
secretion was decreased by 40% in SHS-exposed HBECs
compared to sham controls (18.2 ± 1.8 μA/cm2 for sham
10.7 ± 1.3 μA/cm2 for SHS, n = 19 inserts from 3 donors,
p < 0.01). These data suggest that inhibition of Cl- secre-
tion in HBECs by SHS is time-dependent.
We next investigated whether inhibition of Cl- secretion
by SHS was reversible. HBECs were exposed to air or SHS
(5 - 10 ppm CO) for 180 min then the mucosal surface
was rinsed with warm PBS three times prior to an over-
night recovery period with the inserts bathed on the sero-
sal side in fresh medium in a new tissue culture plate.
Even after an overnight recovery period forskolin-stimu-
lated Cl- secretion in the SHS-exposed HBECs was still
decreased compared to sham controls (Fig. 3B).
Inhibition of forskolin-stimulated Cl- secretion is not 
dependent on CO concentration and filtering SHS reduces 
its impact
To examine the relationship between amount of exposure
as measured by CO and inhibition of Cl- secretion we
increased the exposure chamber CO concentration to 100
ppm from 5 ppm. SHS with 100 ppm CO, a level above
that which one would expect with environmental SHS
exposure, appeared to inhibit forskolin-stimulated ISC (13
± 1.6 μA/cm2 for sham vs. 9.6 ± 1.3 μA/cm2 for SHS, n =
11 inserts, 3 donors), though the difference did not reach
statistical significance when analyzing either the raw data
or the normalized data (p = 0.1 and 0.3, respectively). The
lack of a direct relationship between CO concentration
and the degree of Cl- secretion inhibition by SHS sug-
gested the hypothesis that the particulate phase rather
than the gaseous phase of the smoke was responsible for
the effect [7] because CO resides in the gaseous phase of
SHS. To test this, we sealed the inlet to the exposure cham-
ber with a 2.0 micrometer Teflo filter (Pall, Inc.) to trap
particulate, but not gaseous SHS constituents. With the fil-
ter in place CO concentration inside the exposure cham-
ber could still be modulated, but a 180 min SHS exposure
(5-10 ppm CO) did not significantly reduce forskolin-
stimulated Cl- secretion (Fig. 4, n = 8 inserts, 2 donors).
These data support the hypothesis that a filterable, per-
haps particulate component of SHS causes inhibition of
Cl- secretion.
SHS does not affect cAMP production or PKA activity
Forskolin activates Cl- secretion in HBECs by stimulating
transmembrane adenylate cyclase (tm-AC) to increase cel-
lular cAMP levels. cAMP then binds to PKA causing release
of catalytic PKA subunits that phosphorylate CFTR. There-
fore, we performed experiments to determine if SHS
inhibited Cl- secretion by interrupting this signaling cas-
cade. HBE cells were exposed to air or SHS (5 ppm CO, 30
min) and then stimulated with forskolin after which total
cell lysates were collected. Forskolin stimulation elevated
cAMP levels equivalently in both the sham and SHS-
exposed cells, suggesting that the SHS-mediated inhibi-
tion of Cl- secretion is not due to a defect in tm-AC activity
(Fig. 5A, n = 4 inserts for sham and 3 inserts for SHS, p =
0.6. Note: 1 insert exposed to SHS was an outlier with a
cAMP level > 200 pmol/ml). Using a similar experimental
design, there was no statistical difference in whole-cell
PKA activity between sham and SHS-exposed cells,
though there was a trend toward less PKA activity in SHS-
exposed HBECs (Fig. 5B, n = 12 inserts, 3 donors, p = 0.4
by unpaired t-test with Welch's correction).
Acute exposure to SHS inhibits both apical Cl- 
conductance and basolateral K+ conductance
Because SHS did not appear to affect cAMP signaling, we
next investigated the effects of SHS on cAMP-dependent
ion conductances. cAMP-stimulated Cl- secretion depends
on activation of both apical membrane CFTR [21] and
basolateral membrane K+ channels [22]. Therefore, we
investigated the effect of SHS on both.
To test the hypothesis that SHS inhibited Cl- secretion by
decreasing apical membrane Cl-  conductance, we per-Respiratory Research 2009, 10:120 http://respiratory-research.com/content/10/1/120
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formed Ussing chamber studies in which the basolateral
membrane was permeabilized with nystatin [23]. Sham or
SHS-exposed HBECs were mounted in Ussing chambers
in the presence of a mucosal-to-serosal Cl- gradient (30:1)
and then the basolateral membrane was permeabilized
with 50 μM nystatin. Permeabilization was confirmed by
the inability of amiloride to reduce ISC. Application of for-
skolin resulted in a diffusive Cl- current (ICl) seen as a
downward deflection in the current tracing, that could be
inhibited by the CFTR blocker GlyH-101 (Fig. 6A). These
studies indicated that SHS exposure inhibited 35% of for-
skolin-stimulated ICl (-19.1 ± 2.6 μA/cm2 for sham vs. -
11.8 ± 1.8 μA/cm2 for SHS, p = 0.03) and GlyH-101-sen-
sitive ICl (23.2 ± 3.6 μA/cm2 for sham vs. 14.9 ± 2.8 μA/
cm2 for SHS, n = 14 inserts, 3 donors, p = 0.08) (Fig 6B).
We next investigated the effects of SHS exposure on baso-
lateral K+ conductance. In these experiments, sham or
SHS-exposed HBE cells were initially bathed in symmetri-
cal high K+ solutions and then the apical membrane was
permeabilized with 10 μM amphotericin B [24] in the
presence of 100 μM ouabain (to inhibit Na+/K+ ATPase
activity) and 2 μM forskolin (to activate tm-AC). A
mucosal-to-serosal K+ gradient (25:1) was established by
exchanging approximately 20 volumes (60 ml into a 3 ml
Ussing chamber volume) of the serosal bath for a low K+
solution. A diffusive K+ current (IK) was seen as an upward
deflection in the current tracing that peaked to varying
degrees and then fell to a stable plateau. The resulting
steady-state IK was inhibited by Ba2+ (Fig. 7A). Because the
peak occurred during the solution exchange and was vari-
able both in timing and amplitude, we used the Ba2+-sen-
sitive change in IK as our measurement of basolateral
membrane K+ conductance. SHS exposure reduced basola-
teral K+ conductance by 50% (Fig. 7B). Taken together,
our data suggest that SHS-reduced epithelial Cl- secretion
involves inhibition of both apical membrane CFTR and
basolateral K+ channels.
Discussion
We investigated the effects of SHS on airway epithelial cell
ion transport using a system that approximates in vivo SHS
exposure and is similar in design to ones used for in vivo
SHS toxicology [16,25] and in vitro primary smoke expo-
sure [26,27]. Environmental monitoring suggests that
SHS raises the CO concentration of indoor rooms and car
interiors to approximately 2.5 - 6 ppm [10,14]. Our data
demonstrate that it is feasible to expose HBECs at physio-
logical temperature and humidity to this level of SHS
without causing significant generalized disruption of epi-
thelial integrity, as demonstrated by lack of effects on RT
and LDH release. A limitation of this system is that some
components of SHS may be lost as smoke passes through
the exposure apparatus. During SHS exposure, HBECs in
our system are exposed to approximately 45 ng nicotine/
ml/cm2 (Fig. 1E) when CO is 5 ppm. This is equivalent to
a nicotine concentration of 270 nM, approximately 120×
lower than the 33 μM measured in the expectorated spu-
tum of smokers immediately following smoking of a sin-
gle cigarette [27]. To our knowledge, the amount of
nicotine found in the airways of children exposed to SHS
is unknown, but it is likely that it is significantly less than
that found in smokers because of the dilution and aging
of SHS in room air.
SHS exposure is associated with diseases that are also asso-
ciated with impaired MCC, including asthma, chronic rhi-
nosinusitis, and lower airways infections [3,4,28], but the
cellular mechanisms by which SHS might impair MCC
remain incompletely characterized. One hypothesis is
that SHS impairs epithelial ion transport because abnor-
Inhibition of forskolin-stimulated Cl- secretion is time- dependent Figure 3
Inhibition of forskolin-stimulated Cl- secretion is 
time-dependent. A) Normalized change in ISC after forsko-
lin stimulation is similar between sham (open circles) and 
SHS-exposed (shaded circles) HBECs at 3 min, but decreased 
at 10 and 60 min (* p ≤ 0.05 by unpaired t-test, n = 8 inserts, 
2 donors and 17 inserts, 3 donors, respectively). Change in 
forskolin-stimulated ISC is further decreased in the SHS-
exposed group at 180 min (*** p ≤ 0.001 by unpaired t-test, n 
= 19 inserts, 3 donors). Normalized ISC for sham-exposed 
HBECs remains 1 because each time-point is normalized 
independently. B) Normalized change in ISC after forskolin 
stimulation is still decreased after an overnight recovery 
period (*** p ≤ 0.001 by unpaired t-test, n = 12 inserts, 3 
donors).Respiratory Research 2009, 10:120 http://respiratory-research.com/content/10/1/120
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mal epithelial ion transport can negatively affect MCC
[29]. For example, in cystic fibrosis (CF) the near total
absence or dysfunction of CFTR, the primary cAMP-
dependent Cl- channel in airway epithelial cells, causes
altered salt and water transport by both surface epithelial
cells [30,31] and submucosal glands [32] that results in
impaired MCC and chronic mucopurulent sinusitis and
bronchitis. Furthermore, even partial decreases in CFTR
expression or function may have clinical implications.
Epidemiological data suggest that heterozygote carriers of
CFTR mutations (who do not have CF) have an increased
prevalence of asthma [33] and chronic rhinosinusitis [34]
compared to the general population, and there is a higher
prevalence of CFTR missense mutations in people with
asthma than in the general population [35]. Therefore,
intermediately decreased CFTR function, as observed with
SHS exposure in the present study, may result in clinically
significant changes in MCC in some circumstances.
Some evidence suggests that cigarette smoke inhibits
CFTR-dependent Cl- transport in vivo [9], and we and oth-
ers have demonstrated that water-soluble components of
cigarette smoke inhibit Cl- secretion in vitro [6,7]. A limi-
tation of these studies was the reliance on extracts of ciga-
rette smoke that may or may not accurately represent the
chemical composition of whole (or gaseous) cigarette
smoke [27,36]. We report here that exposure of the
mucosal surface of well-differentiated HBECs to SHS did
not affect amiloride-sensitive Na+ absorption but inhib-
ited forskolin-stimulated and ATP-stimulated ISC, meas-
ures of the epithelial anion (Cl-, HCO3
-) secretion that
drives fluid secretion. Using radioisotopic Cl- flux meas-
urements, we previously demonstrated that CSE specifi-
cally inhibited Cl-  secretion [6]. Our studies here
demonstrated that the decrease in forskolin-stimulated ISC
was completely accounted for by a decrease in bumeta-
nide-sensitive ISC (Fig. 2B, right) or a decrease in CFTRinh-
172-sensitive ISC, agreeing with our previous data and sug-
gesting that SHS acts similarly to CSE with respect to inhi-
bition of CFTR-dependent Cl- secretion.
Our data do not directly identify the compound (or com-
pounds) in SHS that inhibit Cl- secretion in HBECs. CO is
an unlikely candidate because it did not correlate with the
degree of inhibition of Cl- secretion. Interestingly, the rel-
Filtered SHS does not reduce forskolin-stimulated Cl- secre- tion Figure 4
Filtered SHS does not reduce forskolin-stimulated 
Cl- secretion. A 2 μm Teflo air sampling filter (Pall Corpo-
ration) was placed over the inlet port of the exposure cham-
ber. With the filter in place, 180 min SHS exposure (5 ppm 
CO) had no effect on forskolin-stimulated Cl- secretion.
SHS does not appear to affect cAMP production or PKA  activity Figure 5
SHS does not appear to affect cAMP production or 
PKA activity. Whole-cell cAMP (A) and PKA activity (B) 
were measured as described in Materials and Methods. 
There was no statistically significant difference in cAMP pro-
duction or PKA activity between sham and SHS-exposed 
HBECs.Respiratory Research 2009, 10:120 http://respiratory-research.com/content/10/1/120
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ative decrease in forskolin-stimulated ISC by SHS with 100
ppm CO was similar to that of 5 ppm CO but did not
reach statistical significance, suggesting that higher con-
centrations of CO or another gaseous component of SHS
might have an effect on Cl- secretion that is not addressed
by these studies. A particulate component of SHS is a
more likely candidate as we found that the particulate
phase of SHS is necessary for inhibition of Cl- secretion
(Fig. 4), complementing previous data that the particulate
phase of cigarette smoke is sufficient for inhibition of Cl-
secretion [6,7]. Taken together these data strongly impli-
SHS reduces apical membrane Cl- conductance Figure 6
SHS reduces apical membrane Cl- conductance. A) 
Representative current tracings (sham: open circles; SHS: 
shaded circles) demonstrating that nystatin-permeabilization 
of the basolateral membrane allows for a diffusive Cl current 
(ICl) that can be inhibited by GlyH-101, a blocker of CFTR 
channels. Note that addition of amiloride has no effect on 
current, confirming that the intracellular Na+ concentration 
was defined by the serosal bath solution. B) Normalized 
changes in ICl with forskolin and GlyH-101 (** p ≤ 0.01 by 
unpaired t-test).
SHS reduces basolateral membrane K+ conductance Figure 7
SHS reduces basolateral membrane K+ conductance. 
A) Representative tracings (sham: open circles; SHS: shaded 
circles) demonstrating that amphotericin-permeabilization of 
the apical membrane allows for a diffusive K current (IK) that 
can be inhibited by Ba2+, a blocker of many K+ channels. B) 
Normalized changes in IK after sequential application of a K+ 
gradient and Ba2+ (*** p ≤ 0.001 by unpaired t-test).Respiratory Research 2009, 10:120 http://respiratory-research.com/content/10/1/120
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cate a component of the particulate phase of SHS as the
inhibiting agent.
There are multiple ways by which SHS may inhibit forsko-
lin-stimulated Cl- secretion. First, SHS may interfere with
forskolin-activated tm-AC activity or downstream PKA
activity. While our data (Fig. 5) show a trend toward inhi-
bition of PKA activity, they did not achieve statistical sig-
nificance. Furthermore, we measured only whole-cell
cAMP levels and PKA activity; therefore, we cannot
exclude the possibility that SHS alters cAMP levels or PKA
activity in critical subcellular domains [37] and so do not
completely discount the possibility that SHS impairs
cAMP signaling.
Second, SHS may inhibit the ion channels that are
involved in transepithelial Cl- secretion. Previous data
suggest that mainstream cigarette smoke reduces whole-
cell CFTR expression and function in non-polarized Calu-
3 cells [9]. In agreement with these findings, a 30 min SHS
exposure inhibited approximately 25% of forskolin-stim-
ulated and GlyH-101-sensitive ICl in permeabilized HBEC
monolayers (Fig. 6). One possibility to explain the
decrease in CFTR conductance is that SHS contains a com-
pound (or compounds) that rapidly decreases the open
probability (PO) of CFTR as has been shown for oxidized
forms of glutathione [38]. However, Cd2+, a prominent
constituent of cigarette smoke, rapidly increases opening
of CFTR channels [39], so it is likely that if there are effects
of SHS on channel gating that they will be complex and
difficult to tease out. Furthermore, SHS exposure maxi-
mally inhibited Cl- secretion by 180 min but had no effect
after 3 min (Fig. 3A), though there was some variability in
the time-dependence of these responses that may have
been due to difference in cell lot variability or differences
in toxin deposition in the exposure chamber. The time
frame for inhibition of forskolin-stimulated ISC was there-
fore longer than expected for direct channel blockade.
Also, the inhibition of Cl- secretion was not reversible by
washing the mucosal surface of the cells and allowing
them to recover overnight (Fig. 3B), which may be
because the cells or the support on which they are grown
retained some particulate. Because the effect of SHS was
time-dependent and not reversed by washing of the apical
membrane, we speculate that SHS exposure acutely affects
either or both transcriptional and post-transcription mod-
ulation of CFTR expression and trafficking. This mecha-
nism would be consistent with the previously reported
decrease in total cellular CFTR [9].
In addition to inhibiting apical membrane Cl- conduct-
ance, SHS also inhibited 50% of Ba2+-sensitive, basola-
teral membrane K+ conductance (Fig. 7). This finding
suggests that Na+ absorption, which was not affected by
SHS, is not entirely dependent on Ba2+-sensitive K+ chan-
nels. Rather, there may be non-Ba2+-sensitive K+ channels
that help to maintain membrane potential favorable for
Na+ absorption even in the presence of SHS. These con-
ductances may be down-regulated after amiloride block
[40], so that they are absent when examining Cl- secretion
in the presence of amiloride as we have done in these
studies.
We can speculate on a number of possible explanations
for the observed decrease in K+ conductance. First, there
are numerous heavy metals in cigarette smoke that are
pore blockers of K+ channels. Cd2+, for example, inhibits
KCNQ1 channels [41], which participate in transepithe-
lial Cl- secretion in HBECs [42]. Second, membrane con-
ductances can be coordinated in epithelial cells [43], so
the decrease in K+ conductance may be a response to the
reduction in apical membrane Cl- conductance, similar to
the response seen with reduction in apical membrane Na+
conductance [40]. Alternatively, we cannot exclude the
possibility that the primary effect of SHS on Cl- secretion
is decreased basolateral membrane K+ conductance and
that apical membrane Cl- conductance is decreased as a
compensatory response.
Many acute toxicological effects of cigarette smoke are
attributable to oxidative stress [44]. Data regarding the
effects of oxidative stress on CFTR-mediated Cl- secretion
are conflicting, with reports of oxidative stress causing
both increased [45] and decreased [46] Cl-  secretion.
These differences may be explained by differences in cell
culture model systems, the type of oxidant used to gener-
ate oxidative stress, which will generate different types of
oxygen radicals, or differences in the amount of oxidative
stress that was induced.
There are data to support redox-dependent regulation of
both CFTR [38,39,47] and K+ channels including KCNQ1
[48] (reviewed in [49]). Therefore, hypothesizing that oxi-
dative stress caused by SHS results in inhibition of Cl-
secretion is reasonable, particularly because oxidative
stress has been shown to decrease CFTR expression in epi-
thelial cells [50]. However, it is important to point out
that previous investigators were unable to reverse the
effects of cigarette smoke on epithelial Cl- secretion with
antioxidants [7]. Given the thousands of biologically
active compounds in cigarette smoke, further investiga-
tions will be necessary to delineate the molecular mecha-
nism of the observed inhibition.
Although we do not know the mechanism by which ion
conductances are decreased, we do know that pharmaco-
logical agents that promote Cl- secretion, such as activa-
tors of Ca2+-activated Cl- secretion, improve lung function
in patients with CF [51]. Similarly, pharmacological
agents that increase either apical membrane Cl- conduct-Respiratory Research 2009, 10:120 http://respiratory-research.com/content/10/1/120
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ance or basolateral membrane K+ conductance to promote
Cl- secretion in airway epithelial cells might be of clinical
benefit in respiratory diseases caused by SHS exposure or
smoking [52].
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